JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masur, H.
Right arrow Articles by Johnson, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masur, H.
Right arrow Articles by Johnson, W. D., Jr

The Journal of Thoracic and Cardiovascular Surgery, Vol 80, 31-37, Copyright © 1980 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Prosthetic valve endocarditis

H Masur and WD Johnson Jr

The diagnosis, therapy, and complications of prosthetic valve endocarditis (PVE) in 48 patients seen between 1962 and 1978 are reviewed. Staphylococcus epidermidis and diphtheroids were the most common causes of both early and late PVE. These microorganisms were frequently resistant to the penicillins and cephalosporins but were uniformly sensitive to vancomycin. The mortality rate in this series was 69%, with 20% of the deaths attributed to central nervous system emboli and the remainder to cardiac causes. The mortality rate exceeded 75% in patients with any of the following findings: aortic valve infection, nonstreptococcal infecting microorganism, new or increased regurgitant murmurs, or significant congestive heart failure (CHF). The mortality rate was lowest in streptococcal PVE (29%) and in mitral valve PVE (49%). The unacceptably high mortality rate suggests that early replacement of infected prostheses should be considered in all patients except those with uncomplicated streptoccal or mitral valve PVE.


This article has been cited by other articles:


Home page
 JAMAHome page
A. Wang, E. Athan, P. A. Pappas, V. G. Fowler Jr, L. Olaison, C. Pare, B. Almirante, P. Munoz, M. Rizzi, C. Naber, et al.
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
JAMA, March 28, 2007; 297(12): 1354 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. H. A. M. Veltrop, H. Beekhuizen, and J. Thompson
Bacterial Species- and Strain-Dependent Induction of Tissue Factor in Human Vascular Endothelial Cells
Infect. Immun., November 1, 1999; 67(11): 6130 - 6138.
[Abstract] [Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
J. L. Balthazar Jacob, A. Menezes Lorga, L. C. da Silveira, A. Parro, R. V. Ardito, and J. C. Nicolau
Valvular Surgery During Infective Endocarditis: Surgical Mortality and Long-Term Follow-up
Vascular and Endovascular Surgery, June 1, 1994; 28(5): 341 - 348.
[Abstract] [PDF]

Home page
 ScienceHome page
A. Gristina
Biomaterial-centered infection: microbial adhesion versus tissue integration
Science, September 25, 1987; 237(4822): 1588 - 1595.
[Abstract] [PDF]

Home page
 J Biomater ApplHome page
B. Jansen, G. Peters, and G. Pulverer
Mechanisms and Clinical Relevance of Bacterial Adhesion to Polymers
J Biomater Appl, January 1, 1987; 2(4): 520 - 543.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1980 by The American Association for Thoracic Surgery.